Immedica Pharma AB

Industry

  • Distributors
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Impilo, Medical Need
  • Marinus
See more in Biomedtracker

Latest on Immedica Pharma AB

Scrip

Deal Watch: Regeneron Quietly Acquires UK Ophthalmology Firm Oxular

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

Pink Sheet

Pharma Looks To America First: US FDA Holds Overwhelming Lead Over EMA In Novel Approvals

 
• By Bridget Silverman

The US first-approver advantage over the European Union remains stark, with eight of ten novel agents first cleared by the US Food and Drug Administration, according to a Pink Sheet analysis of rece

In Vivo

Will Actinium Be Big Pharma’s Next Radiopharmaceuticals Acquisition?

 
• By David Wild

It has felt lately that there may be not be enough radiopharmaceutical companies to satisfy big pharma’s appetite. First, in December 2023, Eli Lilly and Company purchased POINT Biopharma Global In

Scrip

Deal Watch: Bristol Adds To Vaccines ‘Repertoire,’ Takes ‘Scenic’ View Of Cellular Pathways

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol Looks Into Tolerizing Vaccines,